Our Team.
Jeff Chen
Consultant
Natalie Gier
Consultant
-
Read more2026 PURE Best-in-Class Patient Support Program Winners Announced
Annual PURE Engagement research recognizes pharmaceutical companies delivering leading patient support experiences,...
-
Read moreOvercoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 4
As cell and gene therapies (CGTs) continue to enter the market, treatment centers have become the primary gatekeepers...
-
Read moreFree Drug and Access Equation: What Regeneron’s Otarmeni Decision Reveals About Specialty Product Access
Free drug removes price barriers, but Otarmeni shows why specialty therapy access still depends on PSPs, payers, and logistics.
-
Read moreOvercoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 3
How CGT manufacturers can reduce financial risk and reimbursement burden for treatment centers adopting commercial therapies.
Get in touch.
We create effective treatment experience strategies through experience and market insights.
